Visualizing the mind and body to spark behavioral change. Evcare is dedicated to advancing human well-being through cutting-edge hormone measurement technology derived from academic research. We specialize in analyzing biomarkers found in hair, nails, and saliva. Our core services include: R&D Support: Accelerating product development with scientific evidence. Corporate Wellness: Providing objective stress checks based on physiological data, moving beyond subjective surveys to true health visualization.
株式会社イヴケア（所在地：滋賀県大津市、代表取締役：五十棲計）は、犬の体毛中に含まれるホルモン指標を解析し、生活習慣病リスクをチェックする新サービス「WanScan（ワンスキャン）」を、2025年12月1日（月...
[画像1: https://prtimes.jp/i/127105/4/resize/d127105-4-cb3d55265bd9b7859a0e-0.png ] WanScanの検査キットはオーガニック素材を用いたオシャレな巾着袋型[画像2: https://prtimes.jp/i/127105/4/resize/d127...
[画像: https://prtimes.jp/i/127105/3/resize/d127105-3-e44590d5f0090cee5f65-1.png ] 株式会社イヴケア（本社：滋賀県大津市 代表：五十棲 計 以下、イヴケア）は、毛髪を活用したストレスおよび抗ストレス...
[画像1: https://prtimes.jp/i/127105/2/resize/d127105-2-a0f567995395531eb34c-1.png ] 滋賀県には、子どものプレイセラピーやアートセラピーを行うことのできる施設・機関が不足しています。 子どもは、言葉...
[画像1: https://prtimes.jp/i/127105/1/resize/d127105-1-a9b721967c541f16a114-0.png ] 当プログラムは、株式会社イヴケアが監修する、企業トップと人事・労務責任者が対象の先行エグゼクティブ研修です。 近...
BEL, Inc. is a deep-tech company specializing in materials science and surface engineering, focusing on the development and social implementation of advanced functional surfaces with antibacterial, antiviral, and anti-biofilm properties. The company integrates polymer science, additive manufacturing (3D printing), and surface microstructure control to create next-generation functional coatings for applications in medical devices, infrastructure, environmental systems, and marine environments. BEL actively promotes international collaboration with universities, research institutes, and industrial partners, aiming to advance materials innovation by integrating materials science with digital technologies such as data science and digital twin methodologies.
A drug discovery startup that uses proprietary technology to analyze molecular motion, uncovering previously untargeted disease-causing factors and developing therapeutic drugs. We conduct integrated research from basic studies to clinical development, aiming to create novel treatments.
Remohab is a medical device startup from Osaka University, working on the development of a remote cardiac rehabilitation system. As the first company in the Japan Bio design Program, its participation in Air Water Group is the first M&A exit case in Japan in the DTx (Digital Therapeutics) field. In 2024, its completed Japan’s first physician-initiated Phase III clinical trial for a remote cardiac rehabilitation system, and on June 23, 2025, its product “Remohab CR U” received approval from the Pharmaceuticals and Medical Devices Agency (PMDA). Remohab aims to launch the product in Japan first and promote its nationwide adoption with future global expansion in mind.
bacterico is a biotechnology startup developing personalized healthcare solutions based on an individual’s own gut microbiome. We isolate, select, and cultivate Bifidobacterium strains from stool samples and enhance them using proprietary culture methods to create personalized probiotic supplements optimized for each person’s gut environment. We also provide evidence-based programs tailored to key life moments, including Mama Flora, which supports maternal and infant health through prenatal gut microbiome care, and Preflora, a personalized nutrition and gut-health program designed specifically for individuals who are actively trying to conceive. Through science-driven, individualized interventions, bacterico aims to bring safe and effective microbiome-based solutions to everyday health.
